Kappa opioid receptor internalisation-induced p38 nuclear translocation suppresses glioma progression

Yong Li1, Wenying Wang2, Han She1

  • 1Department of Anesthesiology, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China.

PubMed
Abstract

Insights

Increased kappa opioid receptor (KOP receptor) expression correlates with better glioma prognosis. KOP receptor agonists show potential as adjuvant therapies, inhibiting tumor growth and promoting apoptosis in preclinical models.

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Perioperative medications may influence outcomes in malignant tumor surgery, including cancer recurrence and metastasis.
  • Glioma, a primary brain tumor, presents significant therapeutic challenges.

Purpose of the Study:

  • To investigate the role of kappa opioid receptor (KOP receptor) in glioma progression and therapeutic potential.
  • To elucidate the molecular mechanisms underlying KOP receptor's effect on glioma cells.

Main Methods:

  • Utilized a multi-level approach: bioinformatics, immunohistochemistry, RNA sequencing, gene expression modulation, in vitro cell assays, and in vivo orthotopic tumor transplantation.
  • Examined KOP receptor expression in clinical glioma samples and animal models.
  • Investigated the impact of KOP receptor manipulation on glioblastoma multiforme (GBM) cell behavior and tumor growth.

Main Results:

  • Higher KOP receptor expression was significantly associated with improved prognosis in glioma patients.
  • KOP receptor overexpression in GBM cells inhibited proliferation, induced cell cycle arrest, and promoted apoptosis in vitro.
  • In vivo studies demonstrated that KOP receptor overexpression suppressed glioma growth and extended survival in mice.
  • Mechanistically, KOP receptor activation led to p38 pathway phosphorylation, influencing downstream gene expression.

Conclusions:

  • Findings support the potential of KOP receptor agonists as adjuvant therapeutic agents for glioma.
  • Targeting the KOP receptor pathway may offer a novel strategy to improve glioma treatment outcomes.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.2K